Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of tedizolid versus linezolid for ventilated hospital-acquired or ventilator-associated bacterial pneumonia
MOH_2017-05-08_000388Phase 3Completed
- Sponsor
- Cubist Pharmaceuticals, Inc.
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) comparing Tedizolid arm with Linezolid control arm (2 arms). Started May 2014; status: completed.
02
Drugs
tedizolidlinezolid
03
Conditions
hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on MOH_2017-05-08_000388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-08_000388.